Surviving the butterfly and the wolf: Mortality trends in systemic lupus erythematosus

Autoimmunity Reviews

Volumn 3, Issue 6, 2004, Pages 423-453

  Borchers, Andrea T ^a   Keen, Carl L ^b   Shoenfeld, Yehuda ^c   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Accelerated atherosclerosis; Comorbidity; Immunosuppressive agents; Racial ethnic epidemiology; Steroids; Survival; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISONE; STEROID;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; CULTURAL FACTOR; DEVELOPED COUNTRY; DISEASE COURSE; DRUG MEGADOSE; DRUG USE; ETHNIC GROUP; HUMAN; INFECTION COMPLICATION; KIDNEY FAILURE; MEDICAL LITERATURE; MEDLINE; MORTALITY; NEPHRITIS; PREVALENCE; PROBABILITY; PROGNOSIS; RACE DIFFERENCE; REVIEW; RISK FACTOR; SOCIOECONOMICS; STATISTICS; STEROID THERAPY; SURVIVAL RATE; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR DISEASE;

ARTERIOSCLEROSIS; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SURVIVAL RATE;

EID: 4444291079     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2004.04.002     Document Type: Review

References (196)

1. Cook C.D., Wedgwood R.J., Craig J.M., Hartmann J.R., Janeway C.A. Systemic lupus erythematosus. Description of 37 cases in children and a discussion of endocrine therapy in 32 of the cases. Pediatrics. 26:1960;570-585
2. Madden J.F. Acute disseminated lupus erythematosus. Arch. Dermatol. Syph. 25:1932;854-875
3. Rose E., Pillsbury D.M. Acute disseminated lupus erythematosus - a systemic disease. Ann. Intern. Med. 12:1939;951-963
4. Jessar R.A., Lamont-Havers R.W., Ragan C. Natural history of lupus erythematosus disseminatus. Ann. Intern. Med. 38:1953;717-731
5. Albert D.A., Hadler N.M., Ropes M.W. Does corticosteroid therapy affect the survival of patients with systemic lupus erythematosus? Arthritis Rheum. 22:1979;945-953
6. Worrall J.G., Snaith M.L., Batchelor J.R., Isenberg D.A. SLE: a rheumatological view. Analysis of the clinical features, serology and immunogenetics of 100 SLE patients during long-term follow-up. Q. J. Med. 74:1990;319-330
7. Hochberg M.C., Boyd R.E., Ahearn J.M., Arnett F.C., Bias W.B., Provost T.T., et al. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients, with emphasis on demographic subsets. Medicine (Baltimore). 64:1985;285-295
8. Estes D., Christian C.L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore). 50:1971;85-95
9. Haserick J.R. Effect of cortisone and corticotropin on prognosis of systemic lupus erythematosus; survey of eighty-three patients with positive plasma L.E. tests. AMA Arch. Dermatol. Syphilol. 68:1953;714-725
10. Hargraves M.M., Richmond H., Morton R. Presentation of two bone marrow elements: the "tart" cell and the "LE" cell. Proc. Staff Meet., Mayo Clin. 23:1948;25-28
11. Haserick J.R. Plasma L.E. test in systemic lupus erythematosus: study of twenty-three patients with positive L.E. tests. JAMA. 146:1951;16. 20 (JAMA 1951; 146:16-20)
12. Dubois E.L. The effect of the L.E. cell test on the clinical picture of systemic lupus erythematosus. Ann. Intern. Med. 38:1953;1265-1294
13. Merrell M., Shulman L.E. Determination of prognosis in chronic disease, illustrated by systemic lupus erythematosus. J. Chronic. Dis. 1:1955;12-32
14. Hench P.S., Kendall E.C., Slocumb C.H., Polley H.F. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report. Proc. Staff Meet., Mayo Clin. 24:1949;181-197
15. Posnick J. Systemic lupus erythematosus. The effect of corticotropin and adrenocorticoid therapy on survival rate. Calif. Med. 98:1963;308-312
16. Jacobs J.C. Childhood-onset systemic lupus erythematosus: modern management and improved prognosis. N. Y. State J. Med. 77:1977;2231-2233
17. Dubois E.L. Systemic lupus erythematosus: recent advances in its diagnosis and treatment. Ann. Intern. Med. 45:1956;163-184
18. Dubois E.L., Commons R.R., Starr P., Stein C.S., Morrison R. Corticoptropin and cortisone treatment for systemic lupus erythematosus. JAMA. 149:1952;995-1002
19. Jacobs J.C. Systemic lupus erythematosus in childhood. Report of thirty-five cases, with discussion of seven apparently induced by anticonvulsant medication, and of prognosis and treatment. Pediatrics. 32:1963;257-264
20. McCombs R.P., Patterson J.F. Factors influencing the course and prognosis of systemic lupus erythematosus. N. Engl. J. Med. 260:1959;1195-1204
21. Pollak V.E., Pirani C.L., Kark R.M. Effect of large doses of prednisone on the renal lesions and life span of patients with lupus glomerulonephritis. J. Lab. Clin. Med. 57:1961;495-511
22. Pollack A.D., Pirani C.L., Schwartz F.D. The natural history of the renal manifestations of systemic lupus erythematosus. J. Lab. Clin. Med. 63:1964;537-550
23. Peterson R.D., Vernier R.L., Good R.A. Lupus erythematosus. Pediatr. Clin. North Am. 10:1963;941-978
24. Singh S., Devidayal, Kumar L., Joshi K. Mortality patterns in childhood lupus - 10 years' experience in a developing country. Clin. Rheumatol. 21:2002;462-465
25. Kumar A., Malaviya A.N., Singh R.R., Singh Y.N., Adya C.M., Kakkar R. Survival in patients with systemic lupus erythematosus in India. Rheumatol. Int. 12:1992;107-109
26. Malaviya A.N., Misra R., Banerjee S., Kumar A., Tiwari S.C., Bhuyan U.N., et al. Systemic lupus erythematosus in North Indian Asians. A prospective analysis of clinical and immunological features. Rheumatol. Int. 6:1986;97-101
27. Trager J., Ward M.M. Mortality and causes of death in systemic lupus erythematosus. Curr. Opin. Rheumatol. 13:2001;345-351
28. Ginzler E.M., Diamond H.S., Weiner M., Schlesinger M., Fries J.F., Wasner C., et al. A multicenter study of outcome in systemic lupus erythematosus: I. Entry variables as predictors of prognosis. Arthritis Rheum. 25:1982;601-611
29. Jonsson H., Nived O., Sturfelt G. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population. Medicine (Baltimore). 68:1989;141-150
30. Manger K., Manger B., Repp R., Geisselbrecht M., Geiger A., Pfahlberg A., et al. Definition of risk factors for death, end stage renal disease, and thromboembolic events in a monocentric cohort of 338 patients with systemic lupus erythematosus. Ann. Rheum. Dis. 61:2002;1065-1070
31. Urowitz M.B., Gladman D.D., Abu-Shakra M., Farewell V.T. Mortality studies in systemic lupus erythematosus. Results from a single center: III. Improved survival over 24 years. J. Rheumatol. 24:1997;1061-1065
32. Abu-Shakra M., Urowitz M.B., Gladman D.D., Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center: II. Predictor variables for mortality. J. Rheumatol. 22:1995;1265-1270
33. Jacobsen S., Petersen J., Ullman S., Junker P., Voss A., Rasmussen J.M., et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus: II. Disease mortality and clinical factors of prognostic value. Clin. Rheumatol. 17:1998;478-484
34. Alamanos Y., Voulgari P.V., Parassava M., Tsamandouraki K., Drosos A.A. Survival and mortality rates of systemic lupus erythematosus patients in northwest Greece. Study of a 21-year incidence cohort. Rheumatology (Oxford). 42:2003;1122-1123
35. Wallace D.J., Podell T., Weiner J., Klinenberg J.R., Forouzesh S., Dubois E.L. Systemic lupus erythematosus-survival patterns. Experience with 609 patients. JAMA. 245:1981;934-938
36. Wallace D.J., Podell T.E., Weiner J.M., Cox M.B., Klinenberg J.R., Forouzesh S., et al. Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980. Am. J. Med. 72:1982;209-220
37. Halberg P., Alsbjørn B., Balsløv J.T., Gerstoft J., Lorenzen I., Ullman S., et al. Systemic lupus erythematosus: follow-up study of 148 patients: I. Classification, clinical and laboratory findings, course and outcome. Clin. Rheumatol. 6:1987;13-21
38. Halberg P., Alsbjørn B., Trolle Balslev J., Lorenzen I., Gerstoft J., Ullman S., et al. Systemic lupus erythematosus. Follow-up study of 148 patients: II. Predictive factors of importance for course and outcome. Clin. Rheumatol. 6:1987;22-26
39. Michet C.J. Jr., McKenna C.H., Elveback L.R., Kaslow R.A., Kurland L.T. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin. Proc. 60:1985;105-113
40. Uramoto K.M., Michet C.J. Jr., Thumboo J., Sunku J., O'Fallon W.M., Gabriel S.E. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum. 42:1999;46-50
41. Siegel M., Holley H.L., Lee S.L. Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956-1965. Arthritis Rheum. 13:1970;802-811
42. Fessel W.J. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch. Intern. Med. 134:1974;1027-1035
43. Siegel M., Lee S.L. The epidemiology of systemic lupus erythematosus. Semin. Arthritis Rheum. 3:1973;1-54
44. Trends in deaths from systemic lupus erythematosus - United States, 1979-1998. Morb. Mortal. Wkly. Rep. 51:2002;371-374
45. Walsh S.J., Algert C., Gregorio D.I., Reisine S.T., Rothfield N.F. Divergent racial trends in mortality from systemic lupus erythematosus. J. Rheumatol. 22:1995;1663-1668
46. Gordon M.F., Stolley P.D., Schinnar R. Trends in recent systemic lupus erythematosus mortality rates. Arthritis Rheum. 24:1981;762-769
47. Kaslow R.A., Masi A.T. Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum. 21:1978;473-479
48. Peschken C.A., Esdaile J.M. Systemic lupus erythematosus in North American Indians: a population based study. J. Rheumatol. 27:2000;1884-1891
49. Kaslow R.A. High rate of death caused by systemic lupus erythematosus among U.S. residents of Asian descent. Arthritis Rheum. 25:1982;414-418
50. Serdula M.K., Rhoads G.G. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum. 22:1979;328-333
51. Ward M.M., Pyun E., Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 38:1995;274-283
52. Neumann K., Wallace D.J., Azen C., Nessim S., Fichman M., Metzger A.L., et al. Lupus in the 1980s: III. Influence of clinical variables, biopsy, and treatment on the outcome in 150 patients with lupus nephritis seen at a single center. Semin. Arthritis Rheum. 25:1995;47-55
53. Reveille J.D., Bartolucci A., Alarcon G.S. Prognosis in systemic lupus erythematosus. Negative impact of increasing age at onset, black race, and thrombocytopenia, as well as causes of death. Arthritis Rheum. 33:1990;37-48
54. Pistiner M., Wallace D.J., Nessim S., Metzger A.L., Klinenberg J.R. Lupus erythematosus in the 1980s: a survey of 570 patients. Semin. Arthritis Rheum. 21:1991;55-64
55. Dubois E.L., Wierzchowiecki M., Cox M.B., Weiner J.M. Duration and death in systemic lupus erythematosus, an analysis of 249 cases. JAMA. 227:1974;1399-1402
56. Siegel M., Gwon N., Lee S.L., Rivero I., Wong W. Survivorship in systemic lupus erythematosus: relationship to race and pregnancy. Arthritis Rheum. 12:1969;117-125
57. Swaak A.J.G., Nieuwenhuis E.J., Smeenk R.J.T. Changes in clinical features of patients with systemic lupus erythematosus followed prospectively over 2 decades. Rheumatol. Int. 12:1992;71-75
58. Cooper G.S., Parks C.G., Treadwell E.L., St. Clair E.W., Gilkeson G.S., Cohen P.L., et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus. 11:2002;161-167
59. Reveille J.D., Moulds J.M., Ahn C., Friedman A.W., Baethge B., Roseman J., et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 41:1998;1161-1172
60. Molina J.F., Molina J., Garcia C., Gharavi A.E., Wilson W.A., Espinoza L.R. Ethnic differences in the clinical expression of systemic lupus erythematosus: a comparative study between African-Americans and Latin Americans. Lupus. 6:1997;63-67
61. Petri M., Perez-Gutthann S., Longenecker J.C., Hochberg M. Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am. J. Med. 91:1991;345-353
62. Ward M.M., Studenski S. Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch. Intern. Med. 150:1990;849-853
63. Vilá L.M., Alarcón G.S., McGwin G. Jr., Friedman A.W., Baethge B.A., Bastian H.M., et al. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Rheumatology (Oxford). 43:2004;358-363. [electronic publication 2003 Nov 17]
64. Pons-Estel B.A., Catoggio L.J., Cardiel M.H., Soriano E.R., Gentiletti S., Villa A.R., et al. The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: ethnic and disease heterogeneity among "Hispanics" Medicine (Baltimore). 83:2004;1-17
65. Studenski S., Allen N.B., Caldwell D.S., Rice J.R., Polisson R.P. Survival in systemic lupus erythematosus. A multivariate analysis of demographic factors. Arthritis Rheum. 30:1987;1326-1332
66. Karlson E.W., Daltroy L.H., Lew R.A., Wright E.A., Partridge A.J., Roberts W.N., et al. The independence and stability of socioeconomic predictors of morbidity in systemic lupus erythematosus. Arthritis Rheum. 38:1995;267-273
67. Alarcón G.S., McGwin G. Jr., Bastian H.M., Roseman J., Lisse J., Fessler B.J., et al. Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group. Arthritis Rheum. 45:2001;191-202
68. Sutcliffe N., Clarke A.E., Gordon C., Farewell V., Isenberg D.A. The association of socio-economic status, race, psychosocial factors and outcome in patients with systemic lupus erythematosus. Rheumatology (Oxford). 38:1999;1130-1137
69. Rivest C., Lew R.A., Welsing P.M., Sangha O., Wright E.A., Roberts W.N., et al. Association between clinical factors, socioeconomic status, and organ damage in recent onset systemic lupus erythematosus. J. Rheumatol. 27:2000;680-684
70. Stoll T., Seifert B., Isenberg D.A. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br. J. Rheumatol. 35:1996;248-254
71. Esdaile J.M., Sampalis J.S., Lacaille D., Danoff D. The relationship of socioeconomic status to subsequent health status in systemic lupus erythematosus. Arthritis Rheum. 31:1988;423-427
72. Alarcón G.S., McGwin G. Jr., Bartolucci A.A., Roseman J., Lisse J., Fessler B.J., et al. Systemic lupus erythematosus in three ethnic groups: IX. Differences in damage accrual. Arthritis Rheum. 44:2001;2797-2806
73. Alarcón G.S., Roseman J.M., McGwin G. Jr., Uribe A., Bastian H.M., Fessler B.J., et al. Systemic lupus erythematosus in three ethnic groups: XX. Damage as a predictor of further damage. Rheumatology (Oxford). 43:2004;202-205. [electronic publication 2003 Aug 15]
74. Karlson E.W., Daltroy L.H., Lew R.A., Wright E.A., Partridge A.J., Fossel A.H., et al. The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum. 40:1997;47-56
75. Mok C.C., Lee K.W., Ho C.T.K., Lau C.S., Wong R.W.S. A prospective study of survival and prognostic indicators of systemic lupus erythematosus in a southern Chinese population. Rheumatology (Oxford). 39:2000;399-406
76. Ward M.M., Pyun E., Studenski S. Mortality risks associated with specific clinical manifestations of systemic lupus erythematosus. Arch. Intern. Med. 156:1996;1337-1344
77. Pollack A.D., Pirani C.L. Renal histologic findings in systemic lupus erythematosus. Mayo Clin. Proc. 44:1969;630-644
78. Tucker L.B., Menon S., Schaller J.G., Isenberg D.A. Adult-and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br. J. Rheumatol. 34:1995;866-872
79. Austin H.A. 3rd, Boumpas D.T., Vaughan E.M., Balow J.E. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int. 45:1994;544-550
80. Baqi N., Moazami S., Singh A., Ahmad H., Balachandra S., Tejani A. Lupus nephritis in children: a longitudinal study of prognostic factors and therapy. J. Am. Soc. Nephrol. 7:1996;924-929
81. Barron K.S., Silverman E.D., Gonzales J., Reveille J.D. Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 36:1993;348-354
82. Nossent J.C. Course and prognostic value of systemic lupus erythematosus disease activity index in black Caribbean patients. Semin. Arthritis Rheum. 23:1993;16-21
83. Taylor H.G., Stein C.M. Systemic lupus erythematosus in Zimbabwe. Ann. Rheum. Dis. 45:1986;645-648
84. Barr R.G., Seliger S., Appel G.B., Zuniga R., D'Agati V., Salmon J., et al. Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol. Dial. Transplant. 18:2003;2039-2046
85. Bastian H.M., Roseman J.M., McGwin G. Jr., Alarcón G.S., Friedman A.W., Fessler B.J., et al. Systemic lupus erythematosus in three ethnic groups: XII. Risk factors for lupus nephritis after diagnosis. Lupus. 11:2002;152-160
86. Vilá L.M., Mayor A.M., Valentin A.H., García-Soberal M., Vilá S. Clinical and immunological manifestations in 134 Puerto Rican patients with systemic lupus erythematosus. Lupus. 8:1999;279-286
87. Buján S., Ordi-Ros J., Paredes J., Mauri M., Matas L., Cortés J., et al. Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients. Ann. Rheum. Dis. 62:2003;859-865
88. Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore). 82:2003;299-308
89. Bellomio V., Spindler A., Lucero E., Berman A., Santana M., Moreno C., et al. Systemic lupus erythematosus: mortality and survival in Argentina. A multicenter study. Lupus. 9:2000;377-381
90. Lee P., Urowitz M.B., Bookman A.A., Koehler B.E., Smythe H.A., Gordon D.A., et al. Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q. J. Med. 46:1977;1-32
91. Caeiro F., Michielson F.M.C., Bernstein R., Hughes G.R.V., Ansell B.M. Systemic lupus erythematosus in childhood. Ann. Rheum. Dis. 40:1981;325-331
92. Fish A.J., Blau E.B., Westberg N.G., Burke B.A., Vernier R.L., Michael A.F. Systemic lupus erythematosus within the first two decades of life. Am. J. Med. 62:1977;99-117
93. Meislin A.G., Rothfield N.F. Systemic lupus erythematosus in childhood. Analysis of 42 cases, with comparative data on 200 adult cases followed concurrently. Pediatrics. 42:1968;37-49
94. Blanco F.J., Gómez-Reino J.J., de la Mata J., Corrales A., Rodríguez-Valverde V., Rosas J.C., et al. Survival analysis of 306 European Spanish patients with systemic lupus erythematosus. Lupus. 7:1998;159-163
95. Bogdanovic R., Nikolic V.V., Pasic S., Dimitrijevic J., Lipkovska-Markovic J., Eric-Marinkovic J., et al. Lupus nephritis in childhood: a review of 53 patients followed at a single center. Pediatr. Nephrol. 19:2004;36-44
96. Mok C.C., Wong R.W., Lau C.S. Lupus nephritis in Southern Chinese patients: clinicopathologic findings and long-term outcome. Am. J. Kidney Dis. 34:1999;315-323
97. Shayakul C., Ong-aj-yooth L., Chirawong P., Nimmannit S., Parichatikanond P., Laohapand T., et al. Lupus nephritis in Thailand: clinicopathologic findings and outcome in 569 patients. Am. J. Kidney Dis. 26:1995;300-307
98. Massardo L., Martínez M.E., Jacobelli S., Villarroel L., Rosenberg H., Rivero S. Survival of Chilean patients with systemic lupus erythematosus. Semin. Arthritis Rheum. 24:1994;1-11
99. Nossent H.C., Henzen-Logmans S.C., Vroom T.M., Berden J.H., Swaak T.J. Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum. 33:1990;970-977
100. McLaughlin J.R., Bombardier C., Farewell V.T., Gladman D.D., Urowitz M.B. Kidney biopsy in systemic lupus erythematosus: III. Survival analysis controlling for clinical and laboratory variables. Arthritis Rheum. 37:1994;559-567
101. Seleznick M.J., Fries J.F. Variables associated with decreased survival in systemic lupus erythematosus. Semin. Arthritis Rheum. 21:1991;73-80
102. Ginzler E.M., Felson D.T., Anthony J.M., Anderson J.J. Hypertension increases the risk of renal deterioration in systemic lupus erythematosus. J. Rheumatol. 20:1993;1694-1700
103. Petri M., Lakatta C., Magder L., Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am. J. Med. 96:1994;254-259
104. Petri M., Perez-Gutthann S., Spence D., Hochberg M.C. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am. J. Med. 93:1992;513-519
105. Abu-Shakra M., Urowitz M.B., Gladman D.D., Gough J. Mortality studies in systemic lupus erythematosus. Results from a single center: I. Causes of death. J. Rheumatol. 22:1995;1259-1264
106. Strand V., Gladman D., Isenberg D., Petri M., Smolen J., Tugwell P. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J. Rheumatol. 26:1999;490-497
107. Nossent J.C. SLICC/ACR Damage Index in Afro-Caribbean patients with systemic lupus erythematosus: changes in and relationship to disease activity, corticosteroid therapy, and prognosis. J. Rheumatol. 25:1998;654-659
108. Cook R.J., Gladman D.D., Pericak D., Urowitz M.B. Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity. J. Rheumatol. 27:2000;1892-1895
109. Hernández-Cruz B., Tapia N., Villa-Romero A.R., Reyes E., Cardiel M.H. Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City. Clin. Exp. Rheumatol. 19:2001;395-401
110. Swaak A.J., Nossent J.C., Bronsveld W., Van Rooyen A., Nieuwenhuys E.J., Theuns L., et al. Systemic lupus erythematosus: I. Outcome and survival: Dutch experience with 110 patients studied prospectively. Ann. Rheum. Dis. 48:1989;447-454
111. Mok C.C., Ho C.T., Wong R.W., Lau C.S. Damage accrual in southern Chinese patients with systemic lupus erythematosus. J. Rheumatol. 30:2003;1513-1519
112. Brunner H.I., Silverman E.D., To T., Bombardier C., Feldman B.M. Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum. 46:2002;436-444
113. Stoll T., Sutcliffe N., Klaghofer R., Isenberg D.A. Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective study. Ann. Rheum. Dis. 59:2000;832-835
114. Nived O., Jönsen A., Bengtsson A.A., Bengtsson C., Sturfelt G. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. J. Rheumatol. 29:2002;1398-1400
115. Rahman P., Gladman D.D., Urowitz M.B., Hallett D., Tam L.S. Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus. Lupus. 10:2001;93-96
116. Zonana-Nacach A., Barr S.G., Magder L.S., Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 43:2000;1801-1808
117. Noël V., Lortholary O., Casassus P., Cohen P., Géné reau T., André M.H., et al. Risk factors and prognostic influence of infection in a single cohort of 87 adults with systemic lupus erythematosus. Ann. Rheum. Dis. 60:2001;1141-1144
118. Iliopoulos A.G., Tsokos G.C. Immunopathogenesis and spectrum of infections in systemic lupus erythematosus. Semin. Arthritis Rheum. 25:1996;318-336
119. Karsh J., Klippel J.H., Balow J.E., Decker J.L. Mortality in lupus nephritis. Arthritis Rheum. 22:1979;764-769
120. Jacobsen S., Petersen J., Ullman S., Junker P., Voss A., Rasmussen J.M., et al. Mortality and causes of death of 513 Danish patients with systemic lupus erythematosus. Scand. J. Rheumatol. 28:1999;75-80
121. Petri M. Infection in systemic lupus erythematosus. Rheum. Dis. Clin. North Am. 24:1998;423-456
122. Urowitz M.B., Bookman A.A., Koehler B.E., Gordon D.A., Smythe H.A., Ogryzlo M.A. The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 60:1976;221-225
123. Rubin L.A., Urowitz M.B., Gladman D.D. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q. J. Med. 55:1985;87-98
124. Ward M.M., Pyun E., Studenski S. Causes of death in systemic lupus erythematosus. Long-term followup of an inception cohort. Arthritis Rheum. 38:1995;1492-1499
125. Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 78:1999;167-175
126. Rosner S., Ginzler E.M., Diamond H.S., Weiner M., Schlesinger M., Fries J.F., et al. A multicenter study of outcome in systemic lupus erythematosus: II. Causes of death. Arthritis Rheum. 25:1982;612-617
127. Ward M.M. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 42:1999;338-346
128. Petri M., Roubenoff R., Dallal G.E., Nadeau M.R., Selhub J., Rosenberg I.H. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet. 348:1996;1120-1124
129. Kitagawa Y., Gotoh F., Koto A., Okayasu H. Stroke in systemic lupus erythematosus. Stroke. 21:1990;1533-1539
130. Ståhl-Hallengren C., Jönsen A., Nived O., Sturfelt G. Incidence studies of systemic lupus erythematosus in Southern Sweden: increasing age, decreasing frequency of renal manifestations and good prognosis. J. Rheumatol. 27:2000;685-691
131. Donadio J.V. Jr., Hart G.M., Bergstralh E.J., Holley K.E. Prognostic determinants in lupus nephritis: a long-term clinicopathologic study. Lupus. 4:1995;109-115
132. Gladman D.D., Urowitz M.B. Morbidity in systemic lupus erythematosus. J. Rheumatol. 14(Suppl. 13):1987;223-226
133. Badui E., Garcia-Rubi D., Robles E., Jimenez J., Juan L., Deleze M., et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology. 36:1985;431-441
134. Haider Y.S., Roberts W.C. Coronary arterial disease in systemic lupus erythematosus. Quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am. J. Med. 70:1981;775-781
135. Bulkley B.H., Roberts W.C. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. A study of 36 necropsy patients. Am. J. Med. 58:1975;243-264
136. Bruce I.N., Gladman D.D., Ibanez D., Urowitz M.B. Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus: II. Predictive factors for perfusion abnormalities. J. Rheumatol. 30:2003;288-291
137. Sella E.M., Sato E.I., Leite W.A., Oliveira Filho J.A., Barbieri A. Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus. Ann. Rheum. Dis. 62:2003;1066-1070
138. Hosenpud J.D., Montanaro A., Hart M.V., Haines J.E., Specht H.D., Bennett R.M., et al. Myocardial perfusion abnormalities in asymptomatic patients with systemic lupus erythematosus. Am. J. Med. 77:1984;286-292
139. Gazarian M., Feldman B.M., Benson L.N., Gilday D.L., Laxer R.M., Silverman E.D. Assessment of myocardial perfusion and function in childhood systemic lupus erythematosus. J. Pediatr. 132:1998;109-116
140. Manzi S., Selzer F., Sutton-Tyrrell K., Fitzgerald S.G., Rairie J.E., Tracy R.P., et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 42:1999;51-60
141. Roman M.J., Shanker B.A., Davis A., Lockshin M.D., Sammaritano L., Simantov R., et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349:2003;2399-2406
142. Asanuma Y., Oeser A., Shintani A.K., Turner E., Olsen N., Fazio S., et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349:2003;2407-2415
143. Manger K., Kusus M., Forster C., Ropers D., Daniel W.G., Kalden J.R., et al. Factors associated with coronary artery calcification in young female patients with SLE. Ann. Rheum. Dis. 62:2003;846-850
144. Svenungsson E., Jensen-Urstad K., Heimbürger M., Silveira A., Hamsten A., de Faire U., et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation. 104:2001;1887-1893
145. Font J., Ramos-Casals M., Cervera R., García-Carrasco M., Torras A., Sisó A., et al. Cardiovascular risk factors and the long-term outcome of lupus nephritis. QJM. 94:2001;19-26
146. Bono L., Cameron J.S., Hicks J.A. The very long-term prognosis and complications of lupus nephritis and its treatment. QJM. 92:1999;211-218
147. Bruce I.N., Urowitz M.B., Gladman D.D., Ibanez D., Steiner G. Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum. 48:2003;3159-3167
148. Urowitz M.B., Gladman D.D. Evolving spectrum of mortality and morbidity in SLE. Lupus. 8:1999;253-255
149. Manzi S., Meilahn E.N., Rairie J.E., Conte C.G., Medsger T.A. Jr., Jansen-McWilliams L., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am. J. Epidemiol. 145:1997;408-415
150. Esdaile J.M., Abrahamowicz M., Grodzicky T., Li Y., Panaritis C., du Berger R., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 44:2001;2331-2337
151. Veres K., Lakos G., Kerenyj A., Szekanecz Z., Szegedi G., Shoenfeld Y., et al. Antiphospholipid antibodies in acute coronary syndrome. Lupus. 13:2004;1-5
152. George J., Harats D., Gilburd B., Afek A., Levy Y., Schneiderman J., et al. Immunolocalization of beta2-glycoprotein I (apolipoprotein H) to human atherosclerotic plaques: potential implications for lesion progression. Circulation. 99:1999;2227-2230
153. George J., Shoenfeld Y., Harats D. The involvement of beta2-glycoprotein I (beta2-GPI) in human and murine atherosclerosis. J. Autoimmun. 13:1999;57-60
154. Shoenfeld Y., Sherer Y., George J., Harats D. Autoantibodies associated with atherosclerosis. Ann. Med. 32(Suppl. 1):2000;37-40
155. Sherer Y., Tenenbaum A., Praprotnik S., Shemesh J., Blank M., Fisman E.Z., et al. Autoantibodies to cardiolipin and beta-2-glycoprotein-I in coronary artery disease patients with and without hypertension. Cardiology. 97:2002;2-5
156. Sherer Y., Tenenbaum A., Praprotnik S., Shemesh J., Blank M., Fisman E.Z., et al. Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies. Cardiology. 95:2001;20-24
157. Sherer Y., Shemesh J., Tenenbaum A., Praprotnik S., Harats D., Fisman E.Z., et al. Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain. Am. J. Cardiol. 86:2000;1306-1311
158. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus. 9:2000;170-175
159. Rahman P., Urowitz M.B., Gladman D.D., Bruce I.N., Genest J. Jr. Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus. J. Rheumatol. 26:1999;2363-2368
160. Bruce I.N., Urowitz M.B., Gladman D.D., Hallett D.C. Natural history of hypercholesterolemia in systemic lupus erythematosus. J. Rheumatol. 26:1999;2137-2143
161. Rahman P., Gladman D.D., Urowitz M.B. Premature coronary artery disease in systemic lupus erythematosus in the absence of corticosteroid use. J. Rheumatol. 27:2000;1323-1325
162. Asherson R.A., Mercey D., Phillips G., Sheehan N., Gharavi A.E., Harris E.N., et al. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann. Rheum. Dis. 46:1987;605-611
163. Voss A., Green A., Junker P. Systemic lupus erythematosus in Denmark: clinical and epidemiological characterization of a county-based cohort. Scand. J. Rheumatol. 27:1998;98-105
164. Gudmundsson S., Steinsson K. Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population. J. Rheumatol. 17:1990;1162-1167
165. Bansal V.K., Beto J.A. Treatment of lupus nephritis: a meta-analysis of clinical trials. Am. J. Kidney Dis. 29:1997;193-199
166. McCurdy D.K., Lehman T.J., Bernstein B., Hanson V., King K.K., Nadorra R., et al. Lupus nephritis: prognostic factors in children. Pediatrics. 89:1992;240-246
167. Wajed J., Ahmad Y., Durrington P.N., Bruce I.N. Prevention of cardiovascular disease in systemic lupus erythematosus - proposed guidelines for risk factor management. Rheumatology (Oxford). 43:2004;7-12
168. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines Guidelines for referral and management of systemic lupus erythematosus in adults. Arthritis Rheum. 42:1999;1785-1796
169. Liang M.H., Partridge A.J., Daltroy L.H., Straaton K.V., Galper S.R., Holman H.R. Strategies for reducing excess morbidity and mortality in blacks with systemic lupus erythematosus. Arthritis Rheum. 34:1991;1187-1196
170. Petri M., Spence D., Bone L.R., Hochberg M.C. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine (Baltimore). 71:1992;291-302
171. Bruce I.N., Gladman D.D., Urowitz M.B. Detection and modification of risk factors for coronary artery disease in patients with systemic lupus erythematosus: a quality improvement study. Clin. Exp. Rheumatol. 16:1998;435-440
172. Al-Herz A., Ensworth S., Shojania K., Esdaile J.M. Cardiovascular risk factor screening in systemic lupus erythematosus. J. Rheumatol. 30:2003;493-496
173. Anstey N.M., Bastian I., Dunckley H., Currie B.J. Systemic lupus erythematosus in Australian aborigines: high prevalence, morbidity and mortality. Aust. N. Z. J. Med. 23:1993;646-651
174. Alamanos Y., Voulgari P.V., Siozos C., Katsimpri P., Tsintzos S., Dimou G., et al. Epidemiology of systemic lupus erythematosus in northwest Greece 1982-2001. J. Rheumatol. 30:2003;731-735
175. Kellum R.E., Haserick J.R. Systemic lupus erythematosus. A statistical evaluation of mortality based on a consecutive series of 299 patients. Arch. Intern. Med. 113:1964;200-207
176. Urman J.D., Rothfield N.F. Corticosteroid treatment in systemic lupus erythematosus. Survival studies. JAMA. 238:1977;2272-2276
177. Feinglass E.J., Arnett F.C., Dorsch C.A., Zizic T.M., Stevens M.B. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore). 55:1976;323-339
178. Ballou S.P., Khan M.A., Kushner I. Clinical features of systemic lupus erythematosus: differences related to race and age of onset. Arthritis Rheum. 25:1982;55-60
179. Platt J.L., Burke B.A., Fish A.J., Kim Y., Michael A.F. Systemic lupus erythematosus in the first two decades of life. Am. J. Kidney Dis. 2(1 Suppl 1):1982;212-222
180. Leonhardt T. Long-term prognosis of systemic lupus erythematosus. Acta. Med. Scand., Suppl. 445:1966;440-443
181. Grigor R., Edmonds J., Lewkonia R., Bresnihan B., Hughes G.R. Systemic lupus erythematosus. A prospective analysis. Ann. Rheum. Dis. 37:1978;121-128
182. Feng P.H., Boey M.L. Systemic lupus erythematosus in Chinese: the Singapore experience. Rheumatol. Int. 2:1982;151-154
183. Drenkard C., Villa A.R., Alarcón-Segovia D., Pérez- Vázquez M.E. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J. Rheumatol. 21:1994;1067-1072
184. Cameron J.S., Turner D.R., Ogg C.S., Williams D.G., Lessof M.H., Chantler C., et al. Systemic lupus with nephritis: a long-term study. Q. J. Med. 48:1979;1-24
185. Esdaile J.M., Levinton C., Federgreen W., Hayslett J.P., Kashgarian M. The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q. J. Med. 72:1989;779-833
186. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Lupus nephritis: prognostic factors and probability of maintaining life-supporting renal function 10 years after the diagnosis. Am. J. Kidney Dis. 19:1992;473-479
187. Glidden R.S., Mantzouranis E.C., Borel Y. Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in fifty-five patients. Clin. Immunol. Immunopathol. 29:1983;196-210
188. Lacks S., White P. Morbidity associated with childhood systemic lupus erythematosus. J. Rheumatol. 17:1990;941-945
189. Walravens P.A., Chase H.P. The prognosis of childhood systemic lupus erythematosus. Am. J. Dis. Child. 130:1976;929-933
190. Garin E.H., Donnelly W.H., Fennell R.S. 3rd, Richard G.A. Nephritis in systemic lupus erythematosus in children. J. Pediatr. 89:1976;366-371
191. Abeles M., Urman J.D., Weinstein A., Lowenstein M., Rothfield N.F. Systemic lupus erythematosus in the younger patient: survival studies. J. Rheumatol. 7:1980;515-522
192. Yang L.-Y., Chen W.-P., Lin C.-Y. Lupus nephritis in children - a review of 167 patients. Pediatrics. 94:1994;335-340
193. Hagelberg S., Lee Y., Bargman J., Mah G., Schneider R., Laskin C., et al. Longterm followup of childhood lupus nephritis. J. Rheumatol. 29:2002;2635-2642
194. Vyas S., Hidalgo G., Baqi N., Von Gizyki H., Singh A. Outcome in African-American children of neuropsychiatric lupus and lupus nephritis. Pediatr. Nephrol. 17:2002;45-49
195. Tan E.M., Cohen A.S., Fries J.F., Masi A.T., McShaine D.J., Rothfield N.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 15:1982;1271-1277
196. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum. 40:1997;1725